
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results
2
US Survey Reveals Underuse of Dravet Syndrome–Specific Antiseizure Medications in the Clinic
3
AES Presentations Highlight Zorevunersen as Disease-Modifying Treatment for Dravet Syndrome
4
AES Poster Lays Insights Into EEG and MRI Biomarkers of MOGAD-Related Epilepsy
5





















